Five months after selling a cancer drug to Lilly for up to $2.5 billion, Scorpion has debuted a successor company led by its ...

Gilead's HIV drug lenacapavir earns FDA priority review after strong trial results, with the company planning to double U.S.

It also covers the Hunter Syndrome pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this ...

Now, it's about whether CRISPR Therapeutics can replicate the success across its promising pipeline. Our genetics are like nature's roadmap. Our DNA dictates what color eyes we have, how tall we ...

May 08, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq ... today announced pipeline progress and business updates and reported financial results for the first quarter ended March ...

Mosaic Therapeutics a UK-based oncology company has announced ... He added: “The in licensing of these two clinical-stage assets provides a step change in our development pipeline allowing Mosaic to ...

Endlyz Therapeutics has launched from stealth, unveiling its pipeline of small molecule modulators designed to restore lysosomal function in Parkinson’s disease (PD) and other neurodegenerative ...

The investment will support further development of the Company’s growing pipeline of potent, CNS (central nervous system) penetrant therapeutics based on its aggregate-selective degrader ...

The latest announcement is out from Aclaris Therapeutics ( (ACRS ... This move not only broadens Aclaris’ drug pipeline but also strengthens its financial position with an $80 million private ...

The latest update is out from Foghorn Therapeutics ( (FHTX ... Foghorn is well-equipped to advance its pipeline into 2027, aiming to transform treatments for a variety of cancers.

It covers the Acute Respiratory Distress Syndrome pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Acute Respiratory Distress Syndrome therapeutics ...